Daniel Addison MD
Cardiothoracic Imaging
Associate Professor (w/ tenure), Director, Cardio-Oncology, Vice Chair, AHA Cardiac Imaging Committee
Join to View Full Profile
410 W. 12th AveSte 200Columbus, OH 43212
Phone+1 918-361-6745
Dr. Addison is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Massachusetts General HospitalFellowship, Advanced Cardiac Imaging, 2015 - 2017
Baylor College of MedicineFellowship, Cardiovascular Disease, 2012 - 2015- Baylor College of MedicineResidency, Internal Medicine, 2009 - 2012
Meharry Medical CollegeClass of 2009
Certifications & Licensure
OH State Medical License 2017 - 2025
TX State Medical License 2011 - 2019
MA State Medical License 2015 - 2018
American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council Perspective.Vijay U Rao, Anita Deswal, Daniel Lenihan, Susan Dent, Teresa Lopez-Fernandez
JACC. Cardiooncology. 2025-04-01 - Stress and Hypertension Among African American Female Family Caregivers of Persons Living With Alzheimer Disease and Related Dementias: Protocol for a Pilot Internet-B...Kathy D Wright, Ingrid K Richards Adams, Nathan P Helsabeck, Karen M Rose, Karen O Moss
JMIR Research Protocols. 2025-03-27 - Characterizing Cardiotoxicity of FDA-Approved Soft Tissue Sarcoma Targeted Therapies and Immune Checkpoint Inhibitors: A Systematic Review.Mustafa Houmsse, Andrew Muskara, Damaris Pasca, Arnab Roy, Sana Sughra
Cancers. 2025-02-27
Press Mentions
Heart Disease Is Tied to an Increased Risk of Advanced Breast CancerJanuary 3rd, 2025- Ibrutinib Tied to Worsening Blood Pressure, HypertensionJuly 14th, 2021
Grant Support
- Novel patient biomarkers and mechanisms of TKI associated CardiotoxicityOHIO STATE UNIVERSITY2023–2028
- Therapeutic Strategies to Mitigate Toxicities of Anthracycline-Based TherapeuticsOHIO STATE UNIVERSITY2024–2027
- Therapeutic Strategies to Mitigate Toxicities of Anthracycline-Based TherapeuticsOHIO STATE UNIVERSITY2024–2027
- Early Detection and Mechanisms of Cancer Immunotherapy Associated CardiotoxicityOHIO STATE UNIVERSITY2021–2026
- Early Detection and Mechanisms of Cancer Immunotherapy Associated CardiotoxicityOHIO STATE UNIVERSITY2021–2026
- Early Detection and Mechanisms of Cancer Immunotherapy Associated CardiotoxicityOHIO STATE UNIVERSITY2021–2026
- Early Detection and Mechanisms of Cancer Immunotherapy Associated CardiotoxicityOHIO STATE UNIVERSITY2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
